MDX-1411

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MDX-1411, covering 2010-04-22 to 2013-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. [Phase 1]